TRICCAR Holdings, Inc.

Study Reports Reduction in Human Coronavirus, RSV, Rhinovirus and Influenza vs. Placebo

TRICCAR Holdings, Inc., aka, TRICCAR, today announced Alden Townsend has joined TRICCAR's Scientific Advisory Board.

TRICCAR Holdings, Inc., aka, TRICCAR, today announced an addition to its Board of Directors and Scientific Advisory Board. Steve Hayden joins TRICCAR's Board of Directors as an outside director. Mr.

Average loss of 23.6 pounds at 9 weeks and continued weight stabilization at 2 years.

TRICCAR Holdings, Inc., aka, TRICCAR, today announced it has retained the services of New York-based investment bank Young America Capital to lead its Series B financing in what is expected to be its final financing round before going public.

Eighty-one percent reported decreased pain upon waking and seventy-three percent reported a decrease in pain lasting more than five hours after waking

Over 80% of patients experienced decreases in pain and increase in energy

Average loss of 21 pounds in 8 weeks with no change in diet or exercise